SARS-CoV-2与SARS-CoV的主要生物学特性差异对研发防治COVID-19药物的启示(7)
[39] SWAIM C D, PERNG Y C, ZHAO X, et al. 6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro protease activities[J]. BioRxiv doi: 10.1101/2020.07.01.183020. Preprint.[40] RICHARDSON P ......
您现在查看是摘要页,全文长 1671 字符。